Lei Chen

Lei Chen

Auto-generated profile, based on publicly available information

Lei Chen

Catalytic Hydrogenation Research Center, State Key Laboratory Breeding Base of Green Chemistry-Synthesis Technology, Key Laboratory of Green Pesticides and Cleaner Production Technology of Zhejiang Province, Zhejiang University of Technology, Hangzhou 310014, P. R. China

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2024 in Green Chemistry
Verified
Journal Article
Closed access
PDF file
LCLei Chen
Lei Chen
PYPeiyao Yang
Peiyao Yang
QWQiuying Wang
Qiuying Wang
ZZZhongxiang Zhao
Zhongxiang Zhao
HCHui Cui
Hui Cui
LZLiping Zhu
Liping Zhu
A novel strategy for synthesizing triazolinone with C,N-cycloazomethylimine and dioxazolone has been developed, in which the isocyanate formed in situ from dioxazolone is employed for cyclization instead of the widely used N-acyl nitrene.

1 November 2023 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
LCLei Chen
Lei Chen
ZLZe-Feng Luo
Ze-Feng Luo
PYPeng Ye
Peng Ye
YMYang-Jie Mao
Yang-Jie Mao
ZXZhen-Yuan Xu
Zhen-Yuan Xu
SLShao-Jie Lou
Shao-Jie Lou
A Pd-catalysed Z-selective fluoroarylation of 1,1-difluoroallenes with AgF and various aryl iodides was developed for the first time, constituting an interesting approach for the synthesis of challenging Z-α-trifluoromethyl arylenes.

7 August 2023 in Organic Chemistry Frontiers
Verified
Journal Article
Closed access
PDF file
LCLei Chen
Lei Chen
JPJun Pu
Jun Pu
PYPeng Ye
Peng Ye
SWShuang Wang
Shuang Wang
YMYang-Jie Mao
Yang-Jie Mao
DXDan-Qian Xu
Dan-Qian Xu
A novel fluoroarylation of gem -difluorostyrenes with AgF and (hetero)arenes through a Pd( ii )-catalysed C(aryl)–H activation cascade was developed, constituting an efficient method to access CF 3 -substituted fluorenes and 1,1-diarylmethanes.

4 October 2017 in Tropical Journal of Pharmaceutical Research
Verified
Journal Article
Open access
PDF file
JGJian-Qing Gao
Jian-Qing Gao
SZSu-Xin Zhuang
Su-Xin Zhuang
YWYING WANG
YING WANG
FCFu-Xiao Cao
Fu-Xiao Cao
LCLei Chen
Lei Chen
YWYan Wei
Yan Wei
Purpose: To evaluate the therapeutic effect of Epimedium brevicornum Maxim. extract (EBME) on ovariectomy-induced osteoporosis in rats. Methods: The rats were divided into six experimental groups, viz, control (group 1) and five ovariectomy-induced (OVX) groups. The OVX groups include OVX-inducing agent only group (group 2), OVX with 17ß-estradiol (E2, 25 μg/kg/day, group 3), OVX with 60 mg EBME/kg body weight/day (group 4), OVX with 120 mg EBME/kg body weight/day (group 5) and OVX with 240 mg EBME/kg body weight/day (group 6). The treatment started for the OVX groups with a single weekly dose of OVX inducing agent for 4 weeks, followed by oral daily dose of E2 (group 3) or EBME (groups 4, 5 and 6) for another 16 weeks. Bone mineral density (BMD) of the 4th lumber vertebrae (4LV) and right femur of each rat was estimated. BMD determination was preceded by the measurement of the length of the femur and identification of diaphysis (center). Trabecular microarchitecture was assessed via three representative 4LV. The other parameters measured in this study were serum alkaline phosphatase (ALP), urinary calcium (U-Ca), urinary phosphorus (U-P), urinary creatinine (U-SCr) and osteocalcin (OC) levels. Result: The results showed that the BMD decrease induced by OVX in 4LV and femur was significantly mitigated by high dose of EBME. EBME also protected the trabecular microarchitecture against OVXassociated deterioration, evidenced by decreased bone turnover marker levels in 4LV at high EBME dose. Trabecular number (Tb-N, 3.7 ± 0.2), trabecular thickness (Tb-Th, 0.082 ± 0.011), and trabecular spacing (Tb-Sp, 0.17 ± 0.01) of the highest dose EBME-treated OVX rats ’4LV were significantly (p < 0.05) different from the corresponding values of EBME-free OVX rats. Conclusion: The results reveal that administration of high doses of EBME lasting for 16 weeks not only protected against OVX-induced osteoporosis in rats but was also without the risk of endometrial hyperplasia. Thus, the extract may be a better alternative to other agents in current use for the treatment of postmenopausal osteoporosis in elderly women. However, its efficacy and safety require further investigations. Keywords: Epimedium brevicornum Maxim., Postmenopausal osteoporosis, Ovariectomy, Bone mineral density